Clinical Trial: A Phase 2b Study to Evaluate the Efficacy and Safety of MK‐3655 in Individuals With Pre‐Cirrhotic MASH
Anthony Rodgers, Ira Gantz, Keith D. Kaufman, Samuel S. Engel et al.
Citations
9 citations
Journal
Alimentary Pharmacology & Therapeutics
Topics
Fibroblast Growth Factor Research
Field-Weighted Citation Impact (FWCI)
7.25
article
Clinical Trial: A Phase 2b Study to Evaluate the Efficacy and Safety of MK‐3655 in Individuals With Pre‐Cirrhotic MASH
Anthony Rodgers, Ira Gantz, Keith D. Kaufman, Samuel S. Engel, Annaswamy Raji, Shuai Hu, Matthew L. Rizk, Michael F. Crutchlow, Lianzhe Xu, Heather A. Flynn, Radha Krishnan
article en
9 citations
Abstract
No abstract available for this paper.
Publication Tag
Alimentary Pharmacology & TherapeuticsVol. 61(7)
Institutions
Merck & Co., Inc., Rahway, NJ, USA (United States) (US)